Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in PHATHOM PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 30,631 shares of PHAT (PHATHOM PHARMACEUTICALS INC), worth $508,168 as of 2025-Q4. This is a new position. PHAT represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$508,168
Current Shares
30,631
Total Value Change
-$451,320
Total Shares Change
-62,523
Other major holders of PHAT: RA CAPITAL MANAGEMENT, L.P.
New |
| 30,631 |
- |
| $508,168 |
| 0.0% |
| $16.92 |
33 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $9.74 | 0 |
| 2025-Q1 | Decreased | 99,744 | -15.3% | $625,395 | 0.0% | $6.60 | 0 |
| 2024-Q4 | Increased | 117,803 | +20.2% | $956,561 | 0.0% | $8.00 | 30 |
| 2024-Q3 | Increased | 98,025 | +5.2% | $1.8M | 0.0% | $17.52 | 27 |
| 2024-Q2 | Increased | 93,154 | +622.5% | $959,488 | 0.0% | $10.30 | 40 |